chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A little Sore Arm; Tingling in face; Left side of face numbness; A little Chills; A little Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little Sore Arm), PARAESTHESIA (Tingling in face), HYPOAESTHESIA (Left side of face numbness), CHILLS (A little Chills) and FATIGUE (A little Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (A little Sore Arm), PARAESTHESIA (Tingling in face), HYPOAESTHESIA (Left side of face numbness), CHILLS (A little Chills) and FATIGUE (A little Fatigue). On 23-Feb-2021, PAIN IN EXTREMITY (A little Sore Arm), PARAESTHESIA (Tingling in face), CHILLS (A little Chills) and FATIGUE (A little Fatigue) had resolved. At the time of the report, HYPOAESTHESIA (Left side of face numbness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Pt experienced chills and sweats, swelling, headache, sore neck, redness, itching, hot to the touch at injection site, redness from elbow to shoulder on left arm, a 12 x 8 cm area of erythema and 3 x 5 cm area of firmness.
random heart-racing; random dizziness; occasional headaches; Temperature between 100-102 for 30hrs; flu-like symptoms; extreme burning resulting in fainting; extreme burning; This 42-year-old male patient contactable consumer (reported for himself) received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (lot EN5318,; expiration not provided), via an unspecified route of administration, on 14Feb2021, 12:00 PM (at the age of 42-year-old) as a single dose for COVID-19 immunization, in Left arm. The facility where COVID-19 vaccine was administered was at a hospital. Prior to the vaccination, the patient was not diagnosed with COVID-19. Historical Vaccine included first dose of BNT162B2 (Lot number: el8982) intramuscularly on 24Jan2021 at 09:00 am for COVID-19 immunization on left arm. The patient did not have any other vaccine within four weeks prior to the vaccination. No relevant medical history reported. Concomitant medication included: Levothyroxine 125 "mg", once a day. On 14Feb2021 at 12:15pm, the patient experienced extreme burning resulting in fainting. Ekg normal in ER. Day-2 flu-like symptoms, temp between 100-102 for 30hrs. Day-2 and now day-3, random dizziness, feeling of heart beat, random heart-racing, occasional headaches, no current fever. Events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The clinical outcome of the events extreme burning resulting in fainting, flu-like symptoms, temp between 100-102 for 30hrs, random dizziness, random heart-racing, occasional headaches, was unknown. It was reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
very lethargic lasting about 12-24 hrs; react happened about 24 hrs p/shot (the next day); pt was also difficult to wake up
he notes worsening nocturnal shortness of breath that is unrelieved with his albuterol rescue inhaler.  Reports that he will take a sleep aid and go to bed and wake up approximately 1-1.5 hours later feeling as if he cannot breathe or get a full breath.
Patient received second dose COVID vaccine,  then started to notice a swelling above the injection site about a week later.
Admit 7/30/21 thru ED.  Tested COVID positive 7/25/21.  Acute hypoxic respiratory failure O2 sat 74% on admission - requiring high flow oxygen at 60L. Dx Community acquired Pneumonia, hypoxemia,  Coronavirus disease 2019 viral pneumonia with positive PCR screen. Patient being treated with Remdesivir, dexamethasone Note, patient previously vaccinated with COVID-19 vaccine in April 2021. 8/4/21 Patient transferred from one facility to another facility campus 8/12/21: patient still admitted at the time of this report submission.
Extreme pain and rigidity from hips and down both legs.  Wave-like sensations moving up one side of upper body and then one arm.
I got a rash on my legs. Dermatologist took biopsy on 4/13. Result: "Spongiotic dermatitis, probably similar dermatitis with extracted certificates and statis change". Rash spread to face and neck, swelling on 5/29. Rash spread to chest and stomach and arms. Treatment included prednisone and triamcinoline cream.
Initial report received from a non-healthcare professional on 29-Oct-2013. A male patient whose age and concomitant medications were not reported, received a dose of FLUZONE HD (lot number: U4781AA) on left deltoid via intramuscular route. Patient experienced backache, headache, fatigue and nausea since time of vaccination and symptoms continue to now on 29 October 2013. The events were not resolved. Patient had FLUZONE HD last year. Medical history included hypertension. Patient had penicillin, cephalosporins allergy. List of documents held by sender: none.
Swelling/redness at injection site immediately following injection. Later swelling/redness and itching on entire arm.
After injection patient began to slump over in chair, we slowly lowered him flat on his back, he was not responsive as I asked several times if he could breathe, eyes wide open and muscles completely rigid, yelled for fellow coworker to call 911 as I grabbed an EpiPen (didn't have to use it); patient regained consciousness and responded he could breathe; EMS arrived and took his vitals all which were normal.  After about 30 minutes patient left with his mother.
More than 2 months after the 2nd dose of my vaccine the injection site in my left arm began to hurt. It still does now.
Itching; Rash/all over the body, face, neck and back; Fever; This is a spontaneous report from a contactable consumer reported for himself. A 42-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 08Jan2021 10:30 at single dose for covid-19 immunisation. Medical history included diabetes. Concomitant medication included varicella zoster vaccine (VARICELLA VACCINE).  He noticed a rash on Saturday 09Jan2021 all over the body, face, neck and back; and he had fever. Did not take his temperature. Now today the rash is itching and getting worse. He is planning to get the next injection in 21 days. Mentions he showed the rash to the nurse who gave him this number to call. Information on the Lot/Batch number has been requested. Outcome of event fever was recovered, of others was not recovered.
fever; chills; Gastrointestinal discomfort; malaise; body ache; joint pain; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198) via an unspecified route of administration in the right arm on 04Mar2021 (at the age of 72-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, asthma and hay fever; all from unknown dates. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6201) via an unspecified route of administration in the left arm on 11Feb2021 (at the age of 72-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021, second day after the second shot, the patient experienced fever, chills, gastrointestinal discomfort, malaise, body ache and joint ache. The fever, chills, gastrointestinal discomfort, malaise had begun to subside on 4-5th day after the shot. The body ache remained, but joint pain had been noticeable and had remained . The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  The patient did not receive any treatment for the events fever, chills, gastrointestinal discomfort, malaise and body ache. The patient received treatment for joint pain that included ibuprofen. The clinical outcome of fever, chills, gastrointestinal discomfort, malaise, body ache and joint pain was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
After child received his 4 yr old shots, he had difficulty breathing, tight cough with retractions, audible wheezing, and nasal flaring.  Pulse oximetry sats were 92-93% room air.  Oxygen was administered followed by Epi-Pen Jr and 5 mg Albuterol neb per MD orders
Within 15-minutes of vaccination, the patient became nauseous, clammy, dizzy, and had a near syncopal episode. EMS reported the patient's blood pressure being 70/40 mmHg. EMS administered IV saline and transported patient to  emergency department. In the emergency department, patient stabilized and was discharged shortly after.
The healing time is significantly delayed. 1st scab (about 1 cm)came off on day 31 or 32   (6/27 or 28) After the scab came off it still had a moist area in the center.   7/2 (day 35) it is a little yellow in the center and looks like it needs to form another scab of about 5 mm.  I NEVER got it wet, do not have diabetes, have kept it open to the air about 2 hrs a day most days, loosely covered with gauze until about 2 wk ago, now use a bandaid.  I did need to use the occulsive dressing recommended when around high risk people (water repellent but lets air in)for about 6 hrs on 4 different days up to day 17 and then about 48 hrs three different weekends beginning day 17.  I don't think it was ever infected.  I am a nurse, but do not in clinical practice (do research), so I did not need to keep it occluded as much as clinical nurses would. I saw my primary physician yesterday for a routine annual physical; she did not look at it.  I told her it looked like it was progressing normally but unusually slow.  She and I agreed I would contact CDC today.  I called CDC, was told to continue what I have been doing and contact the people who gave the vaccine for adverse event report.  I question the information provided in the brochure about "normal Reaction Timeline".  Where did they get this data?  Maybe this is the normal times for people years ago when no one covered them up at all.  However, everyone needs to cover them now and Health care providers need to keep them covered even more - all of which will delay healing.  I think the questionnaire we are given post vaccine should ask about healing times.  This may be important information for HCW and others in deciding whether to get the vaccine or not.
Flu-like symptoms, weakness, joint pain that evening. Next morning that was gone, but there was a red rash at the injection site and it still is visible 3 days later. Site bled after injection, rash site was warm to touch. My whole left side (side where injection was given) was sore, even into my left breast.
Within 5 minutes I was extremely flushed, weak and light headed.  I had tingling in hands and arms and a rapid, irregular heart beat. Vaccine staff reported my pulse was thready. They gave me water and put a cold cloth on my neck.  They also fanned me with papers. Within 15 minutes I was better and able to walk out of the appointment.  During the next 2 days I had runs of irregular heart beats and light headed feeling - also recorded on fluctuating heart rate on my Apple watch.  The night of my shot my gums bled significantly from simple tooth brushing and required 5 mouthwash  rinses before it stopped. By the 4th day I was back to normal.
Lot # 0868X (L) Arm PNEUMOVAX vaccine, 4 days from 11/23/08 to 11/27/08 forearm swollen red "hot" to touch, limited mobility to put arm backward
Patient developed erythema over right thigh the morning after vaccination.  Approximately a 2x2cm area of erythema without induration with mild tenderness to palpation observed.  No other symptoms reported.
Patient developed redness, swelling and firmness at the injection site 9 days after receiving her injection.
Vomiting of bile; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting of bile) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VOMITING (Vomiting of bile). At the time of the report, VOMITING (Vomiting of bile) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported. No treatment was taken.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. No treatment information provided.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Mild, Systemic: Weakness-Mild, Additional Details: Patient felt light headed, appeared flushed and sweating. Had shaky hands. Patient was given orange juice and is fine
2 days after vaccination, blisters, erythema, and edema appeared at the site of the DTAP injection. Over a period of hours, the edema and the blistering progressed. Treated with BENADRYL, MOTRIN, ORAPRED, TOPICORT and BACTROBAN. Symptoms improved two days after start of treatment.
Developed convulsions within 48 hrs, inner ear infection, sore throat, upper respiratory infection within 7-14 days, Stiff rt leg painful unable to move within 3wks -lasted 4 to 6 wks.
Chills; Upset stomach; Severe headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at a single dose as vaccine. Medical history included SARS-Cov-2 in Mar2020. Concomitant medications were not reported. The patient was experiencing chills, upset stomach and severe headache on unspecified dates. She took extra strength Tylenol. She asked if she should receive second dose and about efficacy without second dose. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
First three COVID doses were all Pfizer First moderna  Onset of LA local swelling and hives, painful, approx 20hrs after vaccine administration. No systemic sx
Neck and shoulder pain, and pain on injection site for 3 days.  Body aches all day on day 2 and day 3, no fever.  Shortness of breath, albuterol inhaler helped, and rapid pulse-110.
This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in an adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shoulder pain, gastroesophageal reflux, poor sleep, gastrointestinal disorder, headache and feeling bad. On an unknown date, the outcome of the shoulder pain, gastroesophageal reflux, poor sleep, gastrointestinal disorder, headache and feeling bad were unknown. It was unknown if the reporter considered the shoulder pain, gastroesophageal reflux, poor sleep, gastrointestinal disorder, headache and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced unspecified common, minor reactions explained as shoulder hurts, headache, felt crummy, did not sleep well, unspecified GI (gastrointestinal issue) issues, and reflux. The patient did not state the day of SHINGRIX injection nor timing of events.  The patient was feeling better at the time of reporting. The patient was hang up when the patient was told that could not provide medical advice on how to manage events and was referred to her healthcare professional.
Sore throat, hordeolum, early menstrual cramping outside of normal cycle, postural orthostatic tachycardia syndrome upon sitting and standing (POTS),  contracted COVID for the first time in between first and second doses of COVID-19 Pfizer vaccine, sore nipples, inflammation of breasts and uterus, migraine, fatigue, brain fog, missed period, late period, heavy period, long duration of period,  epistaxis, chronic systemic inflammation.
UTI; This is a spontaneous report from a contactable consumer reporting for a parent (mother). A 83-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL1283; Expiration date was not reported), dose 1 via an unspecified route of administration, administered in right arm on 30Jan2021 10:30 (at the age of 83-years-old) as single dose for COVID-19 immunisation. Medical history included blood cholesterol, blood pressure and thyroid condition. It was reported patient had all the usual suspects, as far as, medical conditions for her age including cholesterol, blood pressure, and thyroid. It was also reported that all three were controlled, and not an issue for patient and no further details provided. Patient had no other history. There were no concomitant medications. History of previous immunization with Pfizer vaccine and additional vaccines administered on same date of the Pfizer Suspect included none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine nor experienced any adverse events due to prior vaccinations. The patient experienced UTI (urinary tract infection) on 16Feb2021. The patient underwent urine analysis which resulted positive for UTI on 15Feb2021, and no more information was available. Therapeutic measures were taken because of the event. Patient's doctor prescribed antibiotics for UTI. Patient was scheduled for second COVID-19 Vaccine injection on Saturday, 20Feb2021 and was really concerned about taking the antibiotics with the COVID-19 Vaccine. Reporter asked if it is safe for patient to take the antibiotic, or should she not take the antibiotic, or should she wait to take the antibiotic until after she has had her second COVID-19 Vaccine dose. Caller reported that patient was prescribed Cefdinir for 5 days and does not know how many milligrams Cefdinir, the patient was prescribed. Caller said he had to go to the pharmacy to pick up the Cefdinir prescription, so did not have the Cefdinir NDC, Lot, and Expiration Date. Reporter confirmed that patient has not started taking the Cefdinir. Caller stated that the patient said she would rather get her second COVID-19 Vaccine dose than take the Cefdinir because the COVID-19 Vaccine is more important to her. Reported stated he spoke with patient's doctor via telephone last night and described patient's symptoms to the doctor. The doctor told to have a urine test done the night before this report. And the next day morning patient's doctor called in an antibiotic prescription for patient to take for a UTI. Doctor told reporter that the patient can take the antibiotic and it would not interfere with her second COVID-19 Vaccine dose. The caller stated while he trusts the patient's doctor, he wanted to know what Pfizer had to say. Patient was diagnosed with a UTI on the morning of 16Feb2021. Patient did not have to go to Emergency Room. Patient visited Physician Office due to the event. Outcome of the event was unknown.  Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Chest pain  Shortness of breath Feeling of having a fast beating  Pounding heart
Patient is a 17 year old previously healthy male with history of chest pain, diaphoresis, and troponin leak after his second Sars CoV2 vaccine on 8/24. He was admitted to Hospital early AM on 8/27 after awoken from sleep with chest pain (pressure of 6.5-7/10) and low grade fevers (100.4). His initial troponin was elevated at 1.4, EKG on admission with sinus rhythm in 80s, ECHO with normal ventricular size and function. His pain initially resolved with toradol and ibuprofen however during the day he experienced worsening chest pressure, slight jaw pain, diaphoresis, and increase in his troponin up to 14 prior to transfer. Followup EKG with new 2 mm ST depression in V1. Per report he had a 5 beat run of a wide complex tachycardia before transfer, but this was not confirmed. Patient transferred to Hospital for monitoring, ventricular ectopy improved received Magnesium, Echo repeat with mildly decreased Left ventricular function. ECG unchanged ST elevation. Troponins q 6 downtrended. Patient received Toradol for 24 hrs and then switched to as needed Tylenol and ibuprofen. Infectious work up and labs for myocarditis sent and pending.
VOMITING; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's past medical history included dental extraction, and concurrent conditions included neuropathy, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) dose was not reported, administered on 12-MAR-2021 in the right arm for prophylactic vaccination. Concomitant medications included ibuprofen for pain, and amoxicillin. On 12-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced fatigue. On 13-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from vomiting, and had not recovered from headache, fatigue, and nausea. This report was non-serious.
No adverse reactions at time of vaccine. Pt awoke next am at 0600 with swelling to face. Hives to neck, trunk, and arms were also present.